术中甲状旁腺激素下降多少算过低?正常激素型原发性甲状旁腺功能亢进中的探讨
该回顾性队列研究比较了2002-2019年因正常激素型与经典原发性甲状旁腺功能亢进接受甲状旁腺切除术的患者,发现正常激素型患者术中甲状旁腺激素下降幅度较低即与治愈相关,而下降≥70%与术后低钙血症风险增加相关,提示需调整术中判断参数。
要点
- 正常激素型患者治愈所需术中PTH下降幅度低于经典型(66.4% vs 84.5%)。
- 术中PTH下降≥50%与治愈相关,≥70%与低钙血症风险增加相关。
- 正常激素型患者术后低钙血症风险在PTH下降≥70%时更高(10.4% vs 3.3%)。
核心结论
- 正常激素型原发性甲状旁腺功能亢进患者中,术中甲状旁腺激素下降≥50%预测治愈,≥70%预测术后低钙血症。
研究设计与样本
- 回顾性队列研究,纳入2002-2019年接受甲状旁腺切除术的患者,比较正常激素型与经典原发性甲状旁腺功能亢进。
主要发现
- 1087例患者中127例(11.7%)为正常激素型原发性甲状旁腺功能亢进。
- ROC曲线Youden指数:正常激素型与经典型分别为52%和75%(治愈)、75%和88%(低钙血症)。
关键数值与推荐
- 治愈定义为术后≥6个月血钙<10.3 mg/dL;低钙血症定义为术后≥6个月血钙≤8.4 mg/dL。
- 正常激素型患者术中甲状旁腺激素下降≥50%预测治愈,≥70%预测低钙血症。
临床怎么用
- 对于正常激素型原发性甲状旁腺功能亢进患者,术中甲状旁腺激素下降≥50%可考虑为治愈指标。
- 术中甲状旁腺激素下降≥70%时,应警惕术后低钙血症风险,加强术后钙监测与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In normohormonal primary hyperparathyroidism, parathyroid hormone levels are normal but inappropriately elevated for the degree of hypercalcemia. The study goals were to determine intraoperative parathyroid hormone parameters predictive of (1) cure and (2) hypocalcemia in this subgroup. METHODS: We performed a retrospective cohort study comparing patients who underwent parathyroidectomy (2002-2019) for normohormonal and classic primary hyperparathyroidism. The primary outcomes were cure (calcium <10.3 mg/dL) and hypocalcemia (≤8.4 mg/dL) ≥6 months postoperatively. RESULTS: In the study, 127 of 1,087 patients (11.7%) had normohormonal primary hyperparathyroidism. The groups experienced similar rates of cure (91.3% vs 94.1%, P = .23) and hypocalcemia (3.9% vs 2.9%, P = .53). However, intraoperative parathyroid hormone decline in cured patients was lower in those with normohormonal primary hyperparathyroidism (66.4% vs 84.5%, P < .0001). Receiver operating characteristic curves provided Youden's indices of 52% and 75% (cure) and 75% and 88% (hypocalcemia) for patients with normohormonal and classic primary hyperparathyroidism, respectively. Cure rates with ≥50% intraoperative parathyroid hormone decline were similar (94.1% vs 95.0%, P = .72), but hypocalcemia was more prevalent in patients with normohormonal primary hyperparathyroidism and ≥70% intraoperative parathyroid hormone decline (10.4% vs 3.3%, P = .01). CONCLUSION: In patients with normohormonal primary hyperparathyroidism, intraoperative parathyroid hormone declines of ≥50% and ≥70% were predictive of postoperative cure and hypocalcemia, respectively. These parameters may inform intraoperative decision making and postoperative management.
引用
- Krumeich LN, Finn CB, Fraker DL, et al. How low is too low? Intraoperative parathyroid hormone decline in normohormonal primary hyperparathyroidism. Surgery. 2022. PMID: 36266124. doi:10.1016/j.surg.2022.06.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。